BioCentury
ARTICLE | Company News

MicroDose Therapeutx, Merck deal

August 3, 2009 7:00 AM UTC

Merck exercised an option to use MicroDose's dry powder inhaler technology with an additional undisclosed compound. MicroDose will receive an undisclosed exercise fee. The pharma received the option u...